DTC Advertising Bill Would Mandate Deeper Rx Discounts For Medicaid
This article was originally published in The Pink Sheet Daily
Executive Summary
Legislation introduced by Sens. Wyden (D-Ore.) and Sununu (R-N.H.) is aimed at reducing federal program costs for the most commonly advertised drugs. The Pharmaceutical Advertising & Prudent Purchasing Act also would require a study on ways to reduce Medicare costs for drugs promoted through DTC campaigns.
You may also be interested in...
Sen. Kohl Joins Ranks Of DTC Legislation Sponsors
The Wisconsin Democrat's forthcoming bill would follow the "FDA Safety Act" and the "Pharmaceutical Advertising & Prudent Purchasing Act," both currently pending.
Sen. Kohl Joins Ranks Of DTC Legislation Sponsors
The Wisconsin Democrat's forthcoming bill would follow the "FDA Safety Act" and the "Pharmaceutical Advertising & Prudent Purchasing Act," both currently pending.
House Committee Adds $5.9 Mil. To FDA Budget For Drug Safety, Ad Review
The Appropriations Committee unanimously endorses a managers’ amendment that would provide FDA with an additional $5 mil. for “highest priority drug safety needs” and $884,000 for ad review division staff in fiscal year 2006.